Skip to main content

CORRECTION article

Front. Oncol., 19 May 2021
Sec. Neuro-Oncology and Neurosurgical Oncology
Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.700599

Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features

This article is a correction to:

  1. Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features

    1. Read original article
Mingxiao LiMingxiao Li1Xiaohui RenXiaohui Ren1Gehong DongGehong Dong2Jincheng WangJincheng Wang3Haihui JiangHaihui Jiang1Chuanwei YangChuanwei Yang1Xuzhe ZhaoXuzhe Zhao1Qinghui ZhuQinghui Zhu1Yong CuiYong Cui1Kefu YuKefu Yu4Song Lin,,*Song Lin1,5,6*
  • 1Department of Neurosurgery, National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • 2Department of Pathology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • 3Department of Radiology, Peking University Cancer Hospital, Beijing, China
  • 4Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • 5Beijing Key Laboratory of Brain Tumor, Center of Brain Tumor, Institute for Brain Disorders, Beijing, China
  • 6Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China

A Corrigendum on
Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features

By Li M, Ren X, Dong G, Wang J, Jiang H, Yang C, Zhao X, Zhu Q, Cui Y, Yu K and Lin S (2021). Front. Oncol. 11:627325. doi: 10.3389/fonc.2021.627325

In the published article, there was an error regarding the affiliation for Song Lin. As well as having affiliations 1 and 5, he should also have “6Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: pseudoprogression, MGMT promoter methylation, subventricular zone, IDH wild-type, glioblastoma, random forest, nomogram

Citation: Li M, Ren X, Dong G, Wang J, Jiang H, Yang C, Zhao X, Zhu Q, Cui Y, Yu K and Lin S (2021) Corrigendum: Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological and Molecular Features. Front. Oncol. 11:700599. doi: 10.3389/fonc.2021.700599

Received: 26 April 2021; Accepted: 27 April 2021;
Published: 19 May 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Li, Ren, Dong, Wang, Jiang, Yang, Zhao, Zhu, Cui, Yu and Lin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Song Lin, linsong2005@126.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.